MAPT and Alzheimer disease: 18F-MK6240, 18F-RO69558948, and 18F-PI2620 (Figure 2) also showed excellent pharmacokinetics and high binding affinity selectivity for tau aggregates in AD brain tissue (Hostetler et al., 2016; Honer et al., 2018).